{"id":"W2786847451","doi":"10.1161/circheartfailure.117.004302","title":"Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure","year":2018,"lang":"en","type":"article","venue":"Circulation Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"ca_institutions":"Tellabs (Canada)","funders":"National Heart, Lung, and Blood Institute","keywords":"Sacubitril, Valsartan; Valsartan; Sacubitril; Medicine; Heart failure; Ejection fraction; Internal medicine; ACE inhibitor; Cardiology; Angiotensin-converting enzyme; Blood pressure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002439569,0.0001919554,0.0004432379,0.0001333249,0.000151102,0.00001430023,0.0000743307,0.00008884975,0.0001664679],"category_scores_gemma":[0.00001321525,0.0001275816,0.0001595,0.0003764355,0.000154168,0.0001304945,0.00003314611,0.00007417696,0.00003350837],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005734422,"about_ca_system_score_gemma":0.00004067372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001658766,"about_ca_topic_score_gemma":0.00002793598,"domain_scores_codex":[0.9985442,0.00003435658,0.0004022829,0.0002929282,0.0004760424,0.0002501805],"domain_scores_gemma":[0.9986508,0.00006943454,0.0001575931,0.0005181906,0.000522629,0.00008135979],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00127329,0.001215558,0.8755198,0.001882489,0.001431075,0.000001707024,0.0005942346,0.0002447728,0.003552738,0.007105445,0.1029568,0.004222121],"study_design_scores_gemma":[0.003914955,0.0008938994,0.6753829,0.0003323398,0.0008148446,0.000002896395,0.0004307589,0.0003491237,0.001942341,0.00008687982,0.3156782,0.0001708049],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9556229,0.000146455,0.0138998,0.02299595,0.0002360736,0.006622407,0.00005794952,0.0001136493,0.0003048948],"genre_scores_gemma":[0.9625546,0.000003847972,0.03656228,0.0002047657,0.0001311435,0.0001182797,0.0001706084,0.00002948316,0.0002250149],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2127215,"threshold_uncertainty_score":0.5202625,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0155814723238818,"score_gpt":0.262107633581631,"score_spread":0.2465261612577492,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}